These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 19681933

  • 21. MRI of mandibular osteonecrosis secondary to bisphosphonates.
    García-Ferrer L, Bagán JV, Martínez-Sanjuan V, Hernandez-Bazan S, García R, Jiménez-Soriano Y, Hervas V.
    AJR Am J Roentgenol; 2008 Apr; 190(4):949-55. PubMed ID: 18356441
    [Abstract] [Full Text] [Related]

  • 22. Characteristics of implant failures in patients with a history of oral bisphosphonate therapy.
    Martin DC, O'Ryan FS, Indresano AT, Bogdanos P, Wang B, Hui RL, Lo JC.
    J Oral Maxillofac Surg; 2010 Mar; 68(3):508-14. PubMed ID: 20171469
    [Abstract] [Full Text] [Related]

  • 23. Chronic indurated gingival ulceration. Bisphosphonate-related osteonecrosis of the jaw (BRONJ).
    Mas A, Mascaró JM.
    Arch Dermatol; 2010 Nov; 146(11):1301-6. PubMed ID: 21079075
    [No Abstract] [Full Text] [Related]

  • 24. Osteonecrosis or metastases of the jaw or both? Case report and review of the literature.
    Otto S, Schuler K, Ihrler S, Ehrenfeld M, Mast G.
    J Oral Maxillofac Surg; 2010 May; 68(5):1185-8. PubMed ID: 20144499
    [No Abstract] [Full Text] [Related]

  • 25. Early dental implant failure in patient associated with oral bisphosphonates.
    Gupta R.
    Indian J Dent Res; 2012 May; 23(2):298. PubMed ID: 22945738
    [Abstract] [Full Text] [Related]

  • 26. Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates.
    King AE, Umland EM.
    Pharmacotherapy; 2008 May; 28(5):667-77. PubMed ID: 18447663
    [Abstract] [Full Text] [Related]

  • 27. The incidence of jaw osteonecrosis in multiple myeloma patients treated with bisphosphonates.
    Kraj M, Pogłód R, Maj S, Owczarska K.
    Acta Pol Pharm; 2006 May; 63(5):450-2. PubMed ID: 17357613
    [No Abstract] [Full Text] [Related]

  • 28. Introduction to osteonecrosis of the femoral head (OFH) and osteonecrosis of the jaw (ONJ).
    Kim HK.
    J Musculoskelet Neuronal Interact; 2007 May; 7(4):350-3. PubMed ID: 18094509
    [No Abstract] [Full Text] [Related]

  • 29. [Bisphosphonates and osteonecrosis of the jaws].
    Urade M.
    Clin Calcium; 2007 Feb; 17(2):241-8. PubMed ID: 17272882
    [Abstract] [Full Text] [Related]

  • 30. Oral sodium clodronate induced osteonecrosis of the jaw in a patient with myeloma.
    Montazeri AH, Erskine JG, McQuaker IG.
    Eur J Haematol; 2007 Jul; 79(1):69-71. PubMed ID: 17598839
    [Abstract] [Full Text] [Related]

  • 31. Bisphosphonates and jaw osteonecrosis: the UAMS experience.
    Clarke BM, Boyette J, Vural E, Suen JY, Anaissie EJ, Stack BC.
    Otolaryngol Head Neck Surg; 2007 Mar; 136(3):396-400. PubMed ID: 17321866
    [Abstract] [Full Text] [Related]

  • 32. Dramatic osteonecrosis of the jaw associated with oral bisphosphonates, periodontitis, and dental implant removal.
    Fernández Ayora A, Herion F, Rompen E, Reginster JY, Magremanne M, Lambert F.
    J Clin Periodontol; 2015 Feb; 42(2):190-5. PubMed ID: 25327450
    [Abstract] [Full Text] [Related]

  • 33. Bisphosphonate-related osteonecrosis of the jaws associated with photodynamic therapy.
    Sardella A, Carrassi A, Tarozzi M, Lodi G.
    J Oral Maxillofac Surg; 2011 Oct; 69(10):e314-6. PubMed ID: 21939806
    [No Abstract] [Full Text] [Related]

  • 34. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.
    Mavrokokki T, Cheng A, Stein B, Goss A.
    J Oral Maxillofac Surg; 2007 Mar; 65(3):415-23. PubMed ID: 17307586
    [Abstract] [Full Text] [Related]

  • 35. Clinical aspects and management of bisphosphonates-associated osteonecrosis of the jaws.
    Biasotto M, Chiandussi S, Dore F, Rinaldi A, Rizzardi C, Cavalli F, Di Lenarda R.
    Acta Odontol Scand; 2006 Nov; 64(6):348-54. PubMed ID: 17123911
    [Abstract] [Full Text] [Related]

  • 36. [Maxillar osteonecrosis associated with bisphosphonate treatment and dental implants].
    Savoldelli C, Le Page F, Santini J, Scortecci G, Odin G.
    Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):555-8. PubMed ID: 17631371
    [Abstract] [Full Text] [Related]

  • 37. "Bis-phossy jaws" - high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw.
    Abu-Id MH, Warnke PH, Gottschalk J, Springer I, Wiltfang J, Acil Y, Russo PA, Kreusch T.
    J Craniomaxillofac Surg; 2008 Mar; 36(2):95-103. PubMed ID: 18234504
    [Abstract] [Full Text] [Related]

  • 38. Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals.
    Magopoulos C, Karakinaris G, Telioudis Z, Vahtsevanos K, Dimitrakopoulos I, Antoniadis K, Delaroudis S.
    Am J Otolaryngol; 2007 Mar; 28(3):158-63. PubMed ID: 17499130
    [Abstract] [Full Text] [Related]

  • 39. Jaw osteonecrosis in patients treated with bisphosphonates: an ultrastructural study.
    Perrotta I, Cristofaro MG, Amantea M, Russo E, De Fazio S, Zuccalà V, Conforti F, Amorosi A, Donato G, Tripepi S, Giudice M.
    Ultrastruct Pathol; 2010 Aug; 34(4):207-13. PubMed ID: 20594040
    [Abstract] [Full Text] [Related]

  • 40. Safety of oral bisphosphonates: controlled studies on alveolar bone.
    Jeffcoat MK.
    Int J Oral Maxillofac Implants; 2006 Aug; 21(3):349-53. PubMed ID: 16796276
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.